The Dublin firm that gets to heart of the matter

Trish Dromey talks to CroíValve, a Dublin medical device firm at the cutting-edge of heart valve treatment.

DUBLIN-based company CroíValve is working on developing a medical device to treat tricuspid valve disease — a heart condition which is currently difficult to treat and has a significant impact on survival.

Expecting to have its device ready for human trials by 2020, the company initially plans to target markets in the US and Europe where over half a million new cases of the condition are identified each year. Ultimately, it intends to go after a global market estimated to be worth over €3bn.